Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Recent Advances in Anti-Infective Drug Discovery is Scopus-indexed (Q3, CiteScore 2.5). It is covered by India's One Nation One Subscription scheme for reading access. Published by Bentham Science Publishers.
Checked against the index lists dated .
ISSN 2772-4344Verify ISSN ↗2772-4352Verify ISSN ↗
Publisher: Bentham Science Publishers
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Infectious Diseases | 217 / 361 | 40th | Q3 |
| Pharmacology (medical) | 173 / 278 | 37th | Q3 |
| Drug Discovery | 120 / 161 | 25th | Q3 |
Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2021–present, best quartile Q3, CiteScore 2.5.
Recent Advances in Anti-Infective Drug Discovery is Q3 in Infectious Diseases (rank 217 of 361), Q3 in Pharmacology (medical) (rank 173 of 278) and Q3 in Drug Discovery (rank 120 of 161), by CiteScore 2025.
Recent Advances in Anti-Infective Drug Discovery is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 2.5, quartile Q3, 40th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.304, quartile Q3, with an H-index of 40.
Recent Advances in Anti-Infective Drug Discovery is published by Bentham Science Publishers. Its print ISSN is 2772-4344 and its online ISSN is 2772-4352.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
No — it is not registered as an open-access journal in DOAJ or Scopus.
Recent Advances in Anti-Infective Drug Discovery has an h-index of 9 and a 2-year mean of 0.86 citations per paper (OpenAlex). Its Scopus CiteScore is 2.5, quartile Q3. On 2-year citations it ranks #246 of 354 Scopus journals in Infectious Diseases.
Recent Advances in Anti-Infective Drug Discovery published 17 papers in 2025; its busiest recent year was 2022 with 38. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 88 research articles (2022–2026), authors are most often from India (62.5%), Egypt (8%) and Iran (6.8%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.